The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2013
At a glance
- Drugs Candesartan cilexetil (Primary) ; Antihypertensives
- Indications Cardiovascular disorders; Coronary artery disease; Essential hypertension; Hypertension
- Focus Therapeutic Use
- Acronyms HIJ-CREATE
- 20 Nov 2013 Results of an analysis in patients with chronic kidney disease presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 29 Aug 2012 Substudy results comparing diabetic and non-diabetic cohorts presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 06 Jul 2009 New trial record.